Aldose reductase decreases endoplasmic reticulum stress in ischemic hearts

Chemico-Biological Interactions

Volumn 178, Issue 1-3, 2009, Pages 242-249

  Keith, Rachel J ^a   Haberzettl, Petra ^a   Vladykovskaya, Elena ^a   Hill, Bradford G ^c   Kaiserova, Karin ^a   Srivastava, Sanjay ^a   Barski, Oleg ^a   Bhatnagar, Aruni ^a,b  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

^c University of Alabama at Birmingham   (United States)

Author keywords

Aldose reductase; ER stress; Ischemia; Mouse; Unfolded protein response

Indexed keywords

1 PALMITOYL 2 HYDROXYVALEROYL PHOSPHATIDYLCHOLINE; 1 PALMITOYL 2 OXOVALEROYL PHOSPHATIDYLCHOLINE; ACROLEIN; ALDEHYDE; ALDEHYDE REDUCTASE; HYDROXY 2 NONENAL; PHOSPHATIDYLCHOLINE; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CULTURE; CELL LYSATE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM STRESS; ENZYME METABOLISM; EX VIVO STUDY; GENE OVEREXPRESSION; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; ISOLATED HEART; LIPID PEROXIDATION; MOUSE; NONHUMAN; PROTEIN PHOSPHORYLATION; REPERFUSION; TRANSGENIC MOUSE;

ALDEHYDE REDUCTASE; ALDEHYDES; ANIMALS; BLOTTING, WESTERN; CELLS, CULTURED; ENDOPLASMIC RETICULUM; HUMANS; LIPID PEROXIDATION; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MYOCARDIAL ISCHEMIA; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY;

MUS MUSCULUS;

EID: 59049098116     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2008.10.055     Document Type: Article

References (59)

1. Levi F., Lucchini F., Negri E., and La Vecchia C. Trends in mortality from cardiovascular and cerebrovascular diseases in Europe and other areas of the world. Heart 88 (2002) 119-124
2. Rosamond W., Flegal K., Furie K., Go A., Greenlund K., Haase N., Hailpern S.M., Ho M., Howard V., Kissela B., Kittner S., Lloyd-Jones D., McDermott M., Meigs J., Moy C., Nichol G., O'Donnell C., Roger V., Sorlie P., Steinberger J., Thom T., Wilson M., and Hong Y. Heart disease and stroke statistics-2008 update-A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 117 (2008) E25-E146
3. Downey J.M. Free radicals and their involvement during long-term myocardial ischemia and reperfusion. Annu. Rev. Physiol. 52 (1990) 487-504
4. Bolli R. The late phase of preconditioning. Circ. Res. 87 11 (2000) 972-983
5. Becker L.B. New concepts in reactive oxygen species and cardiovascular reperfusion physiology. Cardiovasc. Res. 61 3 (2004) 461-470
6. Esterbauer H., Schaur R.J., and Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic. Biol. Med. 11 1 (1991) 81-128
7. Eaton P., Li J.M., Hearse D.J., and Shattock M.J. Formation of 4-hydroxy-2-nonenal-modified proteins in ischemic rat heart. Am. J. Physiol. 276 (1999) H935-H943
8. Renner A., Sagstetter M.R., Harms H., Lange V., Gotz M.E., and Elert O. Formation of 4-hydroxy-2-nonenal protein adducts in the ischemic rat heart after transplantation. J. Heart Lung Transplant. 24 6 (2005) 730-736
9. Bhatnagar A. Electrophysiological effects of 4-hydroxynonenal, an aldehydic product of lipid peroxidation, on isolated rat ventricular myocytes. Circ. Res. 76 2 (1995) 293-304
10. Srivastava S., Chandra A., Wang L.F., Seifert Jr. W.E., DaGue B.B., Ansari N.H., Srivastava S.K., and Bhatnagar A. Metabolism of the lipid peroxidation product, 4-hydroxy-trans-2-nonenal, in isolated perfused rat heart. J. Biol. Chem. 273 (1998) 10893-10900
11. Srivastava S., Chandra A., Ansari N.H., Srivastava S.K., and Bhatnagar A. Identification of cardiac oxidoreductase(s) involved in the metabolism of the lipid peroxidation-derived aldehyde-4-hydroxynonenal. Biochem. J. 329 (1998) 469-475
12. Choudhary S., Xiao T., Srivastava S., Zhang W., Chan L.L., Vergara L.A., Van Kuijk F.J.G.M., and Ansari N.H. Toxicity and detoxification of lipid-derived aldehydes in cultured retinal pigmented epithelial cells. Toxicol. Appl. Pharmacol. 204 (2005) 122-134
13. Li Y.B., Cao Z.X., Zhu H., and Trush M.A. Differential roles of 3H-1,2-dithiole-3-thione-induced glutathione, glutathione S-transferase and aldose reductase in protecting against 4-hydroxy-2-nonenal toxicity in cultured cardiomyocytes. Arch. Biochem. Biophys. 439 (2005) 80-90
14. Fukuda A., Nakamura Y., Ohigashi H., Osawa T., and Uchida K. Cellular response to the redox active lipid peroxidation products: induction of glutathione S-transferase P by 4-hydroxy-2-nonenal. Biochem. Biophys. Res. Commun. 236 (1997) 505-509
15. Shinmura K., Bolli R., Liu S.Q., Tang X.L., Kodani E., Xuan Y.T., Srivastava S., and Bhatnagar A. Aldose reductase is an obligatory mediator of the late phase of ischemic preconditioning. Circ. Res. 91 (2002) 240-246
16. Kaiserova K., Tang X.L., Srivastava S., and Bhatnagar A. Role of nitric oxide in regulating aldose reductase activation in the ischemic heart. J. Biol. Chem. 283 (2008) 9101-9112
17. Poli G., Biasi F., and Leonarduzzi G. 4-Hydroxynonenal-protein adducts: a reliable biomarker of lipid oxidation in liver diseases. Mol. Aspects Med. 29 (2008) 67-71
18. Stone M.P., Cho Y.J., Huang H., Kim H.Y., Kozekov I.D., Kozekova A., Wang H., Minko I.G., Lloyd R.S., Harris T.M., and Rizzo C.J. Interstrand DNA cross-links induced by alpha,beta-unsaturated aldehydes derived from lipid peroxidation and environmental sources. Acc. Chem. Res. 41 (2008) 793-804
19. Zemski Berry K.A., and Murphy R.C. Characterization of acrolein-glycerophosphoethanolamine lipid adducts using electrospray mass spectrometry. Chem. Res. Toxicol. (1920) 1342-1351
20. Grune T., and Davies K.J. The proteasomal system and HNE-modified proteins. Mol. Aspects Med. 24 4-5 (2003) 195-204
21. Azfer A., Niu J., Rogers L.M., Adamski F.M., and Kolattukudy P.E. Activation of endoplasmic reticulum stress response during the development of ischemic heart disease. Am. J. Physiol. Heart Circ. Physiol. 291 3 (2006) H1411-H1420
22. Thuerauf D.J., Marcinko M., Gude N., Rubio M., Sussman M.A., and Glembotski C.C. Activation of the unfolded protein response in infarcted mouse heart and hypoxic cultured cardiac myocytes. Circ. Res. 99 3 (2006) 275-282
23. Glembotski C.C. The role of the unfolded protein response in the heart. J. Mol. Cell. Cardiol. 44 (2008) 453-459
24. Boyce M., and Yuan J. Cellular response to endoplasmic reticulum stress: a matter of life or death. Cell Death Differ. 13 3 (2006) 363-373
25. Glembotski C.C. Endoplasmic reticulum stress in the heart. Circ. Res. 101 (2007) 975-984
26. Schroder M., and Kaufman R.J. The mammalian unfolded protein response. Annu. Rev. Biochem. 74 (2005) 739-789
27. Xu C., Bailly-Maitre B., and Reed J.C. Endoplasmic reticulum stress: cell life and death decisions. J. Clin. Invest. 115 10 (2005) 2656-2664
28. Srivastava S., Spite M., Trent J.O., West M.B., Ahmed Y., and Bhatnagar A. Aldose reductase-catalyzed reduction of aldehyde phospholipids. J. Biol. Chem. 279 (2004) 53395-53406
29. O'Connell T.D., Rodrigo M.C., and Simpson P.C. Isolation and culture of adult mouse cardiac myocytes. Methods Mol. Biol. 357 (2007) 271-296
30. Guo Y., Wu W.J., Qiu Y., Tang X.L., Yang Z., and Bolli R. Demonstration of an early and a late phase of ischemic preconditioning in mice. Am. J. Physiol. 275 (1998) H1375-H1387
31. Kaiserova K., Srivastava S., Hoetker J.D., Awe S.O., Tang X.L., Cai J., and Bhatnagar A. Redox activation of aldose reductase in the ischemic heart. J. Biol. Chem. 281 22 (2006) 15110-15120
32. Li Q., Guo Y., Xuan Y.T., Lowenstein C.J., Stevenson S.C., Prabhu S.D., Wu W.J., Zhu Y., and Bolli R. Gene therapy with inducible nitric oxide synthase protects against myocardial infarction via a cyclooxygenase-2-dependent mechanism. Circ. Res. 92 7 (2003) 741-748
33. West M.B., Hill B.G., Xuan Y.T., and Bhatnagar A. Protein glutathiolation by nitric oxide: an intracellular mechanism regulating redox protein modification. FASEB J. 20 10 (2006) 1715-1717
34. Malone J.I., Knox G., Benford S., and Tedesco T.A. Red cell sorbitol: an indicator of diabetic control. Diabetes 29 11 (1980) 861-864
35. Berliner J.A., and Gharavi N.M. Endothelial cell regulation by phospholipid oxidation products. Free Radic. Biol. Med. 45 2 (2008) 119-123
36. Stevens J.F., and Maier C.S. Acrolein: sources, metabolism, and biomolecular interactions relevant to human health and disease. Mol. Nutr. Food Res. 52 1 (2008) 7-25
37. Srivastava S., Chandra A., Bhatnagar A., Srivastava S.K., and Ansari N.H. Lipid peroxidation product, 4-hydroxynonenal and its conjugate with GSH are excellent substrates of bovine lens aldose reductase. Biochem. Biophys. Res. Commun. 217 (1995) 741-746
38. Ramana K.V., Dixit B.L., Srivastava S., Bhatnagar A., Balendiran G.K., Watowich S.J., Petrash J.M., and Srivastava S.K. Characterization of the glutathione binding site of aldose reductase. Chem. Biol. Interact. 130-132 (2001) 537-548
39. Benedetti A., Comporti M., and Esterbauer H. Identification of 4-hydroxynonenal as a cytotoxic product originating from the peroxidation of liver microsomal lipids. Biochim. Biophys. Acta 620 2 (1980) 281-296
40. Benedetti A., Fulceri R., Ferrali M., Ciccoli L., Esterbauer H., and Comporti M. Detection of carbonyl functions in phospholipids of liver-microsomes in Ccl4-poisoned and Brccl3-poisoned rats. Biochim. Biophys. Acta 712 3 (1982) 628-638
41. Benedetti A., Comporti M., Fulceri R., and Esterbauer H. Cyto-toxic aldehydes originating from the peroxidation of liver microsomal lipids-Identification of 4,5-dihydroxydecenal. Biochim. Biophys. Acta 792 2 (1984) 172-181
42. Rittner H.L., Hafner V., Klimiuk P.A., Szweda L.I., Goronzy J.J., and Weyand C.M. Aldose reductase functions as a detoxification system for lipid peroxidation products in vasculitis. J. Clin. Invest. 103 7 (1999) 1007-1013
43. +-isocitrate dehydrogenase is inactivated through 4-hydroxynonenal adduct formation: an event that precedes hypertrophy development. J. Biol. Chem. 278 46 (2003) 45154-45159
44. Srivastava S., Chandrasekar B., Bhatnagar A., and Prabhu S.D. Lipid peroxidation-derived aldehydes and oxidative stress in the failing heart: role of aldose reductase. Am. J. Physiol. Heart Circ. Physiol. 283 (2002) H2612-H2619
45. Lucas D.T., and Szweda L.I. Declines in mitochondrial respiration during cardiac reperfusion: age-dependent inactivation of alpha-ketoglutarate dehydrogenase. Proc. Nat. Acad. Sci. U.S.A. 96 12 (1999) 6689-6693
46. Musatov A., Carroll C.A., Liu Y.C., Henderson G.I., Weintraub S.T., and Robinson N.C. Identification of bovine heart cytochrome c oxidase subunits modified by the lipid peroxidation product 4-hydroxy-2-nonenal. Biochemistry 41 25 (2002) 8212-8220
47. Veronneau M., Comte B., and Des Rosiers C. Quantitative gas chromatographic-mass spectrometric assay of 4-hydroxynonenal bound to thiol proteins in ischemic/reperfused rat hearts. Free Radic. Biol. Med. 33 10 (2002) 1380-1388
48. Szegezdi E., Duffy A., O'Mahoney M.E., Logue S.E., Mylotte L.A., O'Brien T., and Samali A. ER stress contributes to ischemia-induced cardiomyocyte apoptosis. Biochem. Biophys. Res. Commun. 349 4 (2006) 1406-1411
49. Thuerauf D.J., Hoover H., Meller J., Hernandez J., Su L., Andrews C., Dillmann W.H., McDonough P.M., and Glembotski C.C. Sarco/endoplasmic reticulum calcium ATPase-2 expression is regulated by ATF6 during the endoplasmic reticulum stress response: intracellular signaling of calcium stress in a cardiac myocyte model system. J. Biol. Chem. 276 51 (2001) 48309-48317
50. Mouw G., Zechel J.L., Gamboa J., Lust W.D., Selman W.R., and Ratcheson R.A. Activation of caspase-12, an endoplasmic reticulum resident caspase, after permanent focal ischemia in rat. Neuroreport 14 2 (2003) 183-186
51. Kumar R., Krause G.S., Yoshida H., Mori K., and DeGracia D.J. Dysfunction of the unfolded protein response during global brain ischemia and reperfusion. J. Cereb. Blood Flow Metab. 23 (2003) 462-471
52. West J.D., and Marnett L.J. Alterations in gene expression induced by the lipid peroxidation product, 4-hydroxy-2-nonenal. Chem. Res. Toxicol. 18 11 (2005) 1642-1653
53. Urano F., Wang X.Z., Bertolotti A., Zhang Y.H., Chung P., Harding H.P., and Ron D. Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1. Science 287 5453 (2000) 664-666
54. Liang S.H., Zhang W., McGrath B.C., Zhang P., and Cavener D.R. PERK (eIF2alpha kinase) is required to activate the stress-activated MAPKs and induce the expression of immediate-early genes upon disruption of ER calcium homoeostasis. Biochem. J. 393 (2006) 201-209
55. Srivastava S., Watowich S.J., Petrash J.M., Srivastava S.K., and Bhatnagar A. Structural and kinetic determinants of aldehyde reduction by aldose reductase. Biochemistry 38 (1999) 42-54
56. Ramana K.V., Dixit B.L., Srivastava S., Balendiran G.K., Srivastava S.K., and Bhatnagar A. Selective recognition of glutathiolated aldehydes by aldose reductase. Biochemistry 39 (2000) 12172-12180
57. Martindale J.J., Fernandez R., Thuerauf D., Whittaker R., Gude N., Sussman M.A., and Glembotski C.C. Endoplasmic reticulum stress gene induction and protection from ischemia/reperfusion injury in the hearts of transgenic mice with a tamoxifen-regulated form of ATF6. Circ. Res. 98 9 (2006) 1186-1193
58. Zhang P.L., Lun M., Teng J., Huang J., Blasick T.M., Yin L., Herrera G.A., and Cheung J.Y. Preinduced molecular chaperones in the endoplasmic reticulum protect cardiomyocytes from lethal injury. Ann. Clin. Lab. Sci. 34 4 (2004) 449-457
59. Shintani-Ishida K., Nakajima M., Uemura K., and Yoshida K. Ischemic preconditioning protects cardiomyocytes against ischemic injury by inducing GRP78. Biochem. Biophys. Res. Commun. 345 4 (2006) 1600-1605